American Medicine Today

American Medicine Today

Want to know more about American Medicine Today?Full Bio

 

DR. NIKHIL PALEKAR – NEW ALZHEIMER’S DRUG “LAQEMBI” - 8 19 23

THE FDA RECENTLY GAVE FULL APPROVAL TO A NEW DRUG CALLED LEQEMBI, WHICH IS BEING HAILED AS “A NEW ERA IN ALZHEIMER’S TREATMENT”. WE SPEAK WITH NIKHIL PALEKAR, MD - DIRECTOR OF THE STONY BROOK CENTER OF EXCELLENCE FOR ALZHEIMER’S DISEASE AND DIRECTOR OF THE STONY BROOK ALZHEIMER’S DISEASE CLINICAL TRIALS PROGRAM TO DISCUSS THE DETAILS.


Sponsored Content

Sponsored Content